A promising results for HIV Vaccine in a new study
GAITHERSBURG, MD – VIRxSYS Corporation, a privately held company developing vaccines and RNA therapies for serious human diseases such as HIV and cardiovascular diseases, announced results from its prophylactic HIV vaccine (VRX1023) study in Rhesus Macaque monkeys during a presentation at the 2010 Annual Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco, CA.
[...]








